Does Medicaid cover Strattera in New York?

If you or a loved one has been prescribed Strattera (atomoxetine) for ADHD, one of your first questions is likely: Will my insurance cover this medication? The short answer is yes—most insurance plans do cover Strattera, particularly the generic version. However, coverage details vary significantly depending on your insurance type, state, and specific plan requirements.

This guide breaks down everything you need to know about Strattera insurance coverage in 2025, including commercial insurance, Medicare, Medicaid by state, prior authorization requirements, and cost-saving strategies if you’re paying out of pocket.

Understanding Strattera: Why Coverage Matters

Strattera (atomoxetine) is a non-stimulant ADHD medication FDA-approved for children (age 6+), adolescents, and adults. Unlike stimulant medications such as Adderall or Ritalin, Strattera is not a controlled substance, which can make it easier to prescribe via telehealth and often involves fewer regulatory hurdles.

Despite being off-patent since 2017, brand-name Strattera remains expensive—around $450–$500 per month without insurance. Generic atomoxetine offers significant savings at roughly $100–$150 per month retail, and even lower with discount programs. Because ADHD treatment is often long-term, understanding your insurance coverage can save you thousands of dollars annually.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Does Commercial Insurance Cover Strattera?

The Bottom Line: Yes, with Some Conditions

Most commercial health insurance plans cover Strattera, but coverage terms differ based on whether you’re getting the brand-name or generic version:

• Generic atomoxetine: Widely covered as a preferred generic medication on most formularies, typically placed in Tier 1 or Tier 2. This means lower copays (often $10–$30 per month) and minimal restrictions.

• Brand-name Strattera: Usually classified as a non-preferred brand drug in Tier 3 or Tier 4, resulting in higher copays ($50–$150+) or coinsurance (25–50% of the drug cost). Many insurers have moved brand Strattera to higher tiers or excluded it entirely, given that an equivalent generic is available.

Example tier placements:

• UnitedHealthcare: Generic Tier 1, Brand Tier 3
• Aetna: Generic Tier 2, Brand Tier 4
• Cigna and Humana: Similar patterns, with generic preferred and brand non-preferred

Prior Authorization: What to Expect

Approximately 78% of commercial insurance plans require prior authorization (PA) for Strattera, especially for the brand-name version. Generic atomoxetine often bypasses PA requirements, but not always.

Common PA criteria include:

• Documented ADHD diagnosis (per DSM-5 criteria)
• Evidence of a trial with at least one FDA-approved stimulant medication (e.g., methylphenidate or amphetamine), unless contraindicated
• Clinical rationale for choosing a non-stimulant (such as history of substance use disorder, cardiovascular concerns, or severe stimulant side effects)

Key insight: The #1 reason for Strattera coverage denials is incomplete documentation of these required stimulant trials or missing diagnostic records. Working closely with your prescriber to submit thorough PA paperwork can prevent delays.

Step Therapy Requirements

Most insurers enforce step therapy, meaning you must try a lower-cost or first-line treatment before Strattera is approved. In ADHD treatment, this typically means trying a generic stimulant first (such as generic Adderall or Ritalin).

Exceptions are granted if:

• Stimulants are medically contraindicated (e.g., heart conditions, hypertension)
• You’ve had documented failure or intolerable side effects with stimulants
• Your provider submits a strong clinical justification

If step therapy applies to your plan, expect to provide records of previous ADHD medication trials before approval.

Medicare Part D Coverage for Strattera

Generic Atomoxetine: Covered Universally

Good news for Medicare beneficiaries: All Medicare Part D plans cover generic atomoxetine on their formularies. As of 2025, Medicare eliminated prior authorization requirements for most generic medications, including atomoxetine, making access much smoother.

Typical coverage details:

• Tier placement: Tier 1 or Tier 2 (preferred generic)
• Prior authorization: Generally not required for generic
• Quantity limits: Yes—most plans cap dispensing at 30–60 capsules per 30 days (equivalent to 1–2 capsules daily)

Brand-Name Strattera: Limited or Not Covered

Brand Strattera is rarely covered under Part D plans, and when it is, it sits on a high tier (Tier 4 or specialty tier) with significant cost-sharing. Given that a therapeutically equivalent generic exists, Medicare encourages use of the lower-cost option.

If you need brand Strattera:

• Expect to pay full retail price (~$450–$500/month), or
• Submit a formulary exception request with strong medical justification (e.g., documented intolerance to generic formulation, though this is difficult to prove)

Medicare Advantage (Part C) plans follow the same Part D formulary rules, so expect similar coverage patterns.

State Medicaid Coverage: A State-by-State Breakdown

Medicaid coverage for Strattera varies significantly by state. Below is a detailed look at coverage in six priority states—California, Texas, Florida, New York, Pennsylvania, and Illinois.

California (Medi-Cal)

• Status: ✅ Fully covered without prior authorization
• Restrictions: None—listed on Medi-Cal Rx formulary with standard usage guidelines
• Strengths covered: All FDA-approved strengths (10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100 mg)
• Takeaway: California offers the most straightforward Strattera access among Medicaid programs

Texas Medicaid

• Status: ⚠️ Covered with PA required
• Restrictions:
• Classified as non-preferred on the Texas Preferred Drug List (PDL)
• Step therapy enforced: Must document trial with a preferred stimulant first
• Quantity limit: Typically capped at ~80 mg/day (or equivalent in capsules)
• Takeaway: Texas Medicaid follows strict cost-containment protocols—expect to try stimulants before approval

Florida Medicaid

• Status: 🔒 Covered with quantity limits
• Restrictions:
• Quantity limit: Maximum 1–2 capsules per day (applied across all strengths as of October 2025 formulary update)
• No upfront PA if within quantity limits; PA required if exceeding daily cap
• No step therapy explicitly listed for atomoxetine
• Takeaway: Florida allows coverage but closely monitors dispensing to control costs

New York Medicaid

• Status: ⚠️ Covered with PA
• Restrictions:
• Listed as non-preferred on the Medicaid Pharmacy Drug Program formulary
• Step therapy likely: Documentation of stimulant trial failure required
• Quantity limit: 30-day supply, max 2 capsules/day
• Age restriction: Children under 6 not covered without special approval
• Takeaway: New York Medicaid aligns with national trends requiring stimulant trial first

Pennsylvania Medicaid

• Status: 🔒 Covered with restrictions
• Restrictions:
• Age minimum: ≥6 years only (PA needed if under 6, following FDA labeling)
• Quantity limit: Approximately 30 capsules per 30 days
• ADHD diagnosis required: Must document diagnosis for approval
• No automatic step therapy, but clinical justification needed
• Takeaway: Pennsylvania Medicaid covers Strattera but enforces age and quantity controls

Illinois Medicaid

• Status: ⚠️ Covered with PA
• Restrictions:
• On formulary as non-preferred
• Step therapy enforced: Stimulant trial required first
• Quantity limit: Likely ~80 mg/day maximum
• Age restriction: Under 6 requires special approval
• Takeaway: Similar to Texas and New York—expect PA and documentation of stimulant trial

Strattera Pricing: What to Expect Without Insurance

Brand vs. Generic Cost Comparison

Key takeaway: Generic atomoxetine costs 70–80% less than brand Strattera. If paying out of pocket, always opt for generic unless there’s a documented medical reason to use brand.

Discount Card Programs

Pharmacy discount programs can dramatically reduce out-of-pocket costs:

• GoodRx: Generic atomoxetine as low as $45/month (prices vary by pharmacy and location)
• SingleCare: Similar savings, often $50–$60/month
• Rx Outreach: Nonprofit pharmacy offering atomoxetine at ~$20 for a 90-day supply for eligible low-income individuals

Pro tip: Compare prices across multiple pharmacies in your area. Large chain pharmacies (CVS, Walgreens) often have higher cash prices than independent or grocery store pharmacies (Costco, Walmart, Kroger).

Manufacturer Savings Programs and Patient Assistance

Lilly Savings Card (For Brand Strattera)

If your insurance covers brand Strattera but your copay is high, Lilly offers a savings card that can reduce your out-of-pocket cost to as low as $10 per prescription (covering up to $150 of the copay).

Eligibility requirements:

• Must have commercial (private) insurance that covers Strattera
• Not eligible for Medicare, Medicaid, or other government insurance
• Prescription must be for brand-name Strattera (not generic)

How to access: Visit the Lilly Cares website or ask your pharmacist to apply the savings card at checkout.

Patient Assistance Programs (PAP)

Important update: Lilly discontinued its patient assistance program (Lilly Cares) in 2024, which previously provided free Strattera to uninsured or low-income patients.

Alternative options for uninsured patients:

• PAN Foundation: Offers copay assistance for ADHD medications (income-based eligibility)
• Rx Outreach: Low-cost generic atomoxetine for qualifying individuals
• NeedyMeds: Database of discount programs and assistance resources

Telehealth Coverage for Strattera Prescriptions

Is Telehealth Covered by Insurance?

Yes—telehealth visits for ADHD evaluation and medication management are widely covered by most insurance plans as of 2025. Many states have enacted telehealth parity laws, requiring insurers to reimburse virtual visits at the same rate as in-person appointments.

Major insurers covering ADHD telehealth:

• Aetna
• UnitedHealthcare
• Blue Cross Blue Shield
• Cigna
• Humana
• Most state Medicaid programs

Coverage typically includes:

• Initial ADHD diagnostic evaluation
• Medication management follow-ups
• Therapy and counseling sessions

Strattera-Specific Telehealth Advantages

Because Strattera is a non-controlled medication, there are no federal DEA restrictions on telehealth prescribing. This is a significant advantage over stimulant medications, which may require an initial in-person visit under certain state laws or DEA regulations.

What this means for you:

• You can get a Strattera prescription entirely through telehealth (no in-person visit required)
• Refills and follow-up visits can be conducted virtually
• Insurance typically covers telehealth visits with the same copay as office visits

How Klarity Health Can Help

Navigating ADHD treatment and insurance coverage can feel overwhelming—especially when dealing with prior authorizations, formulary restrictions, and cost concerns. Klarity Health makes the process simpler by connecting you with licensed psychiatric providers who specialize in ADHD care via secure telehealth visits.

Why Choose Klarity for Your Strattera Prescription?

✅ Fast provider availability: Get an appointment within 24–48 hours, not weeks
✅ Transparent pricing: Know exactly what you’ll pay upfront—whether using insurance or cash pay
✅ Flexible payment options: Klarity accepts most major insurance plans and offers affordable self-pay rates
✅ Experienced ADHD specialists: Providers understand insurance requirements, including PA and step therapy documentation
✅ End-to-end support: Klarity helps coordinate prescription fulfillment and can assist with prior authorization if needed

Whether you’re starting ADHD treatment for the first time or switching medications, Klarity’s providers can evaluate your symptoms, discuss treatment options (including Strattera), and prescribe medication during your first visit if clinically appropriate.

Tips for Maximizing Your Strattera Insurance Coverage

1. Always Request Generic First

Unless there’s a documented medical reason to use brand Strattera, ask your provider to prescribe generic atomoxetine. This avoids higher copays and reduces the likelihood of prior authorization denials.

2. Keep Documentation Ready

If PA is required, have the following information ready:

• ADHD diagnostic evaluation and test results
• Records of previous ADHD medications tried (especially stimulants)
• Documentation of side effects or reasons for discontinuation
• Clinical notes supporting why Strattera is medically necessary

3. File an Appeal if Denied

If your insurance denies coverage, you have the right to appeal. Work with your provider to submit a letter of medical necessity explaining why Strattera is the appropriate treatment. Success rates for appeals can be as high as 50–60% with strong clinical justification.

4. Check for Quantity Limit Exceptions

If your prescribed dose exceeds your plan’s quantity limit (e.g., you need 100 mg daily but your plan caps at 80 mg), your provider can request a quantity limit exception with clinical rationale.

5. Explore Manufacturer and Nonprofit Assistance

Even if you have insurance, high deductibles or copays can make treatment unaffordable. Don’t overlook savings cards, patient assistance programs, and nonprofit resources that can reduce costs significantly.

What to Do If Your Insurance Won’t Cover Strattera

If your insurance denies coverage or the cost is too high, you have several options:

Option 1: Try a Covered Alternative

Your insurance may prefer a different ADHD medication. Common alternatives include:

• Stimulants: Generic Adderall (amphetamine salts), methylphenidate (Ritalin, Concerta)
• Other non-stimulants: Intuniv (guanfacine), Kapvay (clonidine)
• Newer options: Qelbree (viloxazine), though this may also require PA

Option 2: Use a Pharmacy Discount Program

As noted earlier, GoodRx and similar programs can bring generic atomoxetine down to ~$45/month, often cheaper than insurance copays.

Option 3: Consider Cash-Pay Telehealth Services

Some telehealth platforms (including Klarity Health) offer transparent cash-pay pricing for visits and can help you find the lowest-cost pharmacy options for your prescription.

Option 4: Appeal the Denial

Work with your provider to submit a formal insurance appeal with supporting documentation. Many plans approve coverage on reconsideration when given strong medical justification.

Frequently Asked Questions

Does insurance cover Strattera for adults?

Yes, most insurance plans cover Strattera (atomoxetine) for adults with ADHD, though prior authorization and step therapy requirements are common. Generic atomoxetine is widely covered on lower tiers.

Is Strattera covered by Medicare?

Yes, all Medicare Part D plans cover generic atomoxetine, typically without prior authorization. Brand Strattera is rarely covered and usually requires a formulary exception.

Do I need prior authorization for generic Strattera?

It depends on your plan. Many commercial insurers do not require PA for generic atomoxetine, but some plans still enforce step therapy (stimulant trial first). Check your specific formulary or call your insurer to confirm.

Can I get Strattera through telehealth with insurance?

Yes. Telehealth visits for ADHD medication management are covered by most insurance plans under telehealth parity laws. Because Strattera is non-controlled, it can be prescribed entirely via telehealth without an in-person visit.

What if my state Medicaid doesn’t cover Strattera?

All states in our analysis (CA, TX, FL, NY, PA, IL) cover atomoxetine on their Medicaid formularies, though restrictions vary. If you’re facing barriers, ask your provider to submit a PA request with clinical justification.

How much does Strattera cost without insurance?

Brand Strattera costs ~$450–$500/month without insurance. Generic atomoxetine costs ~$100–$150 retail, but can be reduced to $45–$60/month with discount cards like GoodRx.

Final Thoughts: Getting the ADHD Treatment You Need

Strattera is covered by most insurance plans in 2025, particularly in its generic form. However, navigating prior authorization, step therapy, and state Medicaid variations requires preparation and persistence. By understanding your plan’s requirements, keeping thorough documentation, and exploring cost-saving programs, you can access affordable ADHD treatment.

If you’re struggling with insurance coverage or simply want a faster, more straightforward path to care, Klarity Health offers expert ADHD evaluations and medication management via telehealth—with transparent pricing, fast appointments, and providers who understand the insurance landscape.

Ready to take the next step? Schedule a consultation with a Klarity provider today and get the support you need to manage your ADHD effectively.

References

1. Shanghai Archives of Psychiatry. (2025). Does Insurance Cover Strattera? 2025 Update on Commercial, Medicare, and Medicaid Coverage. Retrieved from https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/

2. Aetna Better Health Florida. (2024). Medicaid Formulary Updates – Florida Preferred Drug List. Retrieved from https://ch.aetnabetterhealth.com/florida/drug-formulary.html

3. Aetna Better Health Pennsylvania. (2024). Pennsylvania Medicaid Formulary (Kids/MCO). Retrieved from https://fr.aetnabetterhealth.com/pennsylvania/drug-formulary.html

4. Shanghai Archives of Psychiatry. (2025). Strattera Price & Savings Guide 2025: Cash Prices, Manufacturer Programs, and Discount Options. Retrieved from https://shanghaiarchivesofpsychiatry.org/strattera-price-savings-guide/

5. ICANotes. (2025). Telehealth Parity Laws 2025: State-by-State Guide to Insurance Coverage Requirements. Retrieved from https://www.icanotes.com/2022/03/09/telehealth-parity-laws/

📅 RESEARCH CURRENCY STATEMENT
Verified as of: January 4, 2026
Formularies checked: Aetna (2024/2025 updates), UnitedHealthcare (2025 PDL), Cigna (2025), Humana (2025), Kaiser (2025)
Medicaid formularies verified: CA, TX, FL, NY, PA, IL (2024–2025 updates)
GoodRx prices as of: January 2026

Source:

• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=,3
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=,formulations%3B%20TX%20requires%20step%20therapy
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=typically%20sits%20on%20Tier%202,3
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=,name
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=,therapy%20starting%20with%20generic%20stimulants
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=,%2415
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=,Vary%20by%20employer%20formulary%20choices
• https://shanghaiarchivesofpsychiatry.org/strattera-insurance-coverage-2025-commercial-medicare-medicaid/#:~:text=limits%20%28e.g.%2C%202%20capsules%2Fday%29%20%3Acite,Vary%20by%20employer%20formulary%20choices
• https://ch.aetnabetterhealth.com/florida/drug-formulary.html#:~:text=,Added%20Quantity%20Limit
• https://fr.aetnabetterhealth.com/pennsylvania/drug-formulary.html#:~:text=,Quantity%20Level%20Limit%2C%20Age%20Minimum